Single-Pass vs 2-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection for Creation of Pancreatic Adenocarcinoma Organoids

Joseph F. Lacomb, Dennis Plenker, Hervé Tiriac, Juan Carlos Bucobo, Lionel S. D'souza, Asim S. Khokhar, Hardik Patel, Breana Channer, Dimitri Joseph, Maoxin Wu, David A. Tuveson, Ellen Li, Jonathan M. Buscaglia

Research output: Contribution to journalShort surveypeer-review

20 Scopus citations

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has one of the poorest prognoses of all malignancies, with a 5-year survival rate <8%.1,2 Suspicious lesions are typically diagnosed via endoscopic ultrasound–guided fine-needle aspiration or endoscopic ultrasound–guided fine-needle biopsy (EUS-FNB).3 Fewer needle passes decreases the risk of postprocedure complications, including pancreatitis and hemorrhage, while allowing additional needle passes to be used for adjuvant tissue testing, such as organoid creation and DNA sequencing.

Original languageEnglish
Pages (from-to)845-847
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume19
Issue number4
DOIs
StatePublished - Apr 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Single-Pass vs 2-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection for Creation of Pancreatic Adenocarcinoma Organoids'. Together they form a unique fingerprint.

Cite this